Cargando…

T Lymphocytes as Targets for SARS-CoV-2

Despite numerous data on the absence or weak expression of the main functional receptor of SARS-CoV-2 angiotensin-converting enzyme 2 (ACE2) by T cells, it was recently demonstrated that the new coronavirus can efficiently infect T lymphocytes. Here, we analyze the data on the alternative (ACE2-inde...

Descripción completa

Detalles Bibliográficos
Autor principal: Kuklina, Elena M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pleiades Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201263/
https://www.ncbi.nlm.nih.gov/pubmed/35790412
http://dx.doi.org/10.1134/S0006297922060086
_version_ 1784728270367883264
author Kuklina, Elena M.
author_facet Kuklina, Elena M.
author_sort Kuklina, Elena M.
collection PubMed
description Despite numerous data on the absence or weak expression of the main functional receptor of SARS-CoV-2 angiotensin-converting enzyme 2 (ACE2) by T cells, it was recently demonstrated that the new coronavirus can efficiently infect T lymphocytes. Here, we analyze the data on the alternative (ACE2-independent) pathways of cell infection, identified T cell subpopulations that serve as the most plausible targets of SARS-CoV-2, discuss the mechanisms of virus–cell interaction, including both infectious and non-infectious pathways of T lymphocyte regulation, and estimate the role of the virus-dependent damage of T lymphocytes in COVID-19 pathogenesis. Particular attention is paid to regulatory T cells as potential targets of SARS-CoV-2, as well as to the possible involvement of exosomes in the sensitivity of peripheral T cells to the virus.
format Online
Article
Text
id pubmed-9201263
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Pleiades Publishing
record_format MEDLINE/PubMed
spelling pubmed-92012632022-06-17 T Lymphocytes as Targets for SARS-CoV-2 Kuklina, Elena M. Biochemistry (Mosc) Review Despite numerous data on the absence or weak expression of the main functional receptor of SARS-CoV-2 angiotensin-converting enzyme 2 (ACE2) by T cells, it was recently demonstrated that the new coronavirus can efficiently infect T lymphocytes. Here, we analyze the data on the alternative (ACE2-independent) pathways of cell infection, identified T cell subpopulations that serve as the most plausible targets of SARS-CoV-2, discuss the mechanisms of virus–cell interaction, including both infectious and non-infectious pathways of T lymphocyte regulation, and estimate the role of the virus-dependent damage of T lymphocytes in COVID-19 pathogenesis. Particular attention is paid to regulatory T cells as potential targets of SARS-CoV-2, as well as to the possible involvement of exosomes in the sensitivity of peripheral T cells to the virus. Pleiades Publishing 2022-06-16 2022 /pmc/articles/PMC9201263/ /pubmed/35790412 http://dx.doi.org/10.1134/S0006297922060086 Text en © Pleiades Publishing, Ltd. 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Kuklina, Elena M.
T Lymphocytes as Targets for SARS-CoV-2
title T Lymphocytes as Targets for SARS-CoV-2
title_full T Lymphocytes as Targets for SARS-CoV-2
title_fullStr T Lymphocytes as Targets for SARS-CoV-2
title_full_unstemmed T Lymphocytes as Targets for SARS-CoV-2
title_short T Lymphocytes as Targets for SARS-CoV-2
title_sort t lymphocytes as targets for sars-cov-2
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201263/
https://www.ncbi.nlm.nih.gov/pubmed/35790412
http://dx.doi.org/10.1134/S0006297922060086
work_keys_str_mv AT kuklinaelenam tlymphocytesastargetsforsarscov2